SEC Form 4 · accession 0001209191-15-067385
NOVAVAX INC · NVAX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael A McManus Jr.
Director
Period of report
Aug 19, 2015
Accepted (ET)
Aug 21, 2015 · 5:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000694
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 19, 2015 | M | 20,000 | $2.50 | A | 187,590 | D | |
| Common Stock | Aug 19, 2015 | M | 30,000 | $1.83 | A | 217,590 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy)F1 | $2.50 | Aug 19, 2015 | M | 20,000 | D | — | Mar 10, 2021 | Common Stock | 20,000 | 0 | D |
| Stock Option (Right to buy)F2 | $1.83 | Aug 19, 2015 | M | 30,000 | D | — | Mar 2, 2023 | Common Stock | 30,000 | 0 | D |
Explanation of responses
- F1The 20,000 shares exercised on 08/19/2015 pursuant to this stock option vested on 09/10/2011.
- F2The 30,000 shares exercised on 08/19/2015 pursuant to this stock option vested on 09/02/2013.